HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.
We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.
On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo) in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.
Earlier this year, during the IMCAS World Congress, we interviewed three experts in the field of aesthetic medicine and are thrilled to share these interviews !
As a global company, we were delighted to participate in Personal Care and Homecare Ingredients (PCHi) 2025 in Guangzhou, China this year.
HTL Biotechnology made a strong impact this year at IMCAS with a reinforced presence and exciting interactions with our customers and partners.
We’re happy to share that HTL Biotechnology got the new certification ISO 13485.
We’re excited to announce the publication of our first CSR Report!